Six articles including 2299 participants with HR+/HER2- tumor reported ORR data, the pooled RR was 1.78(95%CI:1.35–2.34) by using the fixed effect model (P = 0.29, I2 = 20%) (Fig 5). Here, ERBB2 is linked to neoplasm.